Annual FCF
-$38.74 M
-$14.16 M-57.62%
December 31, 2023
Summary
- As of February 7, 2025, CRMD annual free cash flow is -$38.74 million, with the most recent change of -$14.16 million (-57.62%) on December 31, 2023.
- During the last 3 years, CRMD annual FCF has fallen by -$16.66 million (-75.44%).
- CRMD annual FCF is now -1704.65% below its all-time high of -$2.15 million, reached on December 31, 2009.
Performance
CRMD Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$13.66 M
+$415.00 K+2.95%
September 30, 2024
Summary
- As of February 7, 2025, CRMD quarterly free cash flow is -$13.66 million, with the most recent change of +$415.00 thousand (+2.95%) on September 30, 2024.
- Over the past year, CRMD quarterly FCF has dropped by -$2.62 million (-23.71%).
- CRMD quarterly FCF is now -8589.56% below its all-time high of $160.90 thousand, reached on June 30, 2019.
Performance
CRMD Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$56.15 M
-$4.95 M-9.67%
September 30, 2024
Summary
- As of February 7, 2025, CRMD TTM free cash flow is -$56.15 million, with the most recent change of -$4.95 million (-9.67%) on September 30, 2024.
- Over the past year, CRMD TTM FCF has dropped by -$17.41 million (-44.95%).
- CRMD TTM FCF is now -10274.65% below its all-time high of -$541.20 thousand, reached on March 31, 2009.
Performance
CRMD TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
CRMD Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -57.6% | -23.7% | -45.0% |
| 3 y3 years | -75.4% | -117.4% | -128.5% |
| 5 y5 years | -63.1% | -341.1% | -142.6% |
CRMD Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -71.5% | at low | -149.6% | +21.4% | -148.7% | at low |
| 5 y | 5-year | -156.7% | at low | -1701.1% | +21.4% | -272.1% | at low |
| alltime | all time | -1704.7% | at low | -8589.6% | +21.4% | <-9999.0% | at low |
CorMedix Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$13.66 M(-2.9%) | -$56.15 M(+9.7%) |
| Jun 2024 | - | -$14.07 M(-19.0%) | -$51.20 M(+12.0%) |
| Mar 2024 | - | -$17.37 M(+57.3%) | -$45.70 M(+18.0%) |
| Dec 2023 | -$38.74 M(+57.6%) | -$11.04 M(+26.8%) | -$38.74 M(+14.0%) |
| Sep 2023 | - | -$8.71 M(+1.5%) | -$33.98 M(+8.4%) |
| Jun 2023 | - | -$8.58 M(-17.6%) | -$31.34 M(+11.0%) |
| Mar 2023 | - | -$10.41 M(+65.6%) | -$28.24 M(+14.9%) |
| Dec 2022 | -$24.58 M(+8.8%) | -$6.28 M(+3.5%) | -$24.58 M(-0.9%) |
| Sep 2022 | - | -$6.07 M(+11.0%) | -$24.79 M(-0.8%) |
| Jun 2022 | - | -$5.47 M(-18.9%) | -$25.00 M(+10.5%) |
| Mar 2022 | - | -$6.75 M(+3.9%) | -$22.63 M(+0.2%) |
| Dec 2021 | -$22.58 M(+2.3%) | -$6.50 M(+3.4%) | -$22.58 M(+2.2%) |
| Sep 2021 | - | -$6.28 M(+102.8%) | -$22.09 M(-4.5%) |
| Jun 2021 | - | -$3.10 M(-53.8%) | -$23.15 M(+11.2%) |
| Mar 2021 | - | -$6.70 M(+11.5%) | -$20.81 M(-5.8%) |
| Dec 2020 | -$22.08 M(+46.3%) | -$6.01 M(-18.1%) | -$22.08 M(+10.6%) |
| Sep 2020 | - | -$7.33 M(+867.1%) | -$19.96 M(+20.3%) |
| Jun 2020 | - | -$758.40 K(-90.5%) | -$16.60 M(+5.9%) |
| Mar 2020 | - | -$7.98 M(+104.8%) | -$15.68 M(+3.9%) |
| Dec 2019 | -$15.09 M(-36.5%) | -$3.89 M(-1.9%) | -$15.09 M(-18.0%) |
| Sep 2019 | - | -$3.97 M(-2566.6%) | -$18.39 M(-5.9%) |
| Jun 2019 | - | $160.90 K(-102.2%) | -$19.55 M(-18.7%) |
| Mar 2019 | - | -$7.39 M(+2.6%) | -$24.04 M(+1.2%) |
| Dec 2018 | -$23.75 M(-17.4%) | -$7.20 M(+40.6%) | -$23.75 M(-0.8%) |
| Sep 2018 | - | -$5.12 M(+18.1%) | -$23.95 M(-6.6%) |
| Jun 2018 | - | -$4.34 M(-38.9%) | -$25.65 M(-11.8%) |
| Mar 2018 | - | -$7.09 M(-4.2%) | -$29.07 M(+1.2%) |
| Dec 2017 | -$28.74 M(+28.7%) | -$7.40 M(+8.5%) | -$28.74 M(+3.2%) |
| Sep 2017 | - | -$6.82 M(-12.0%) | -$27.84 M(+0.8%) |
| Jun 2017 | - | -$7.75 M(+14.7%) | -$27.62 M(+16.9%) |
| Mar 2017 | - | -$6.76 M(+4.0%) | -$23.63 M(+5.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2016 | -$22.32 M(+78.0%) | -$6.50 M(-1.5%) | -$22.32 M(+14.7%) |
| Sep 2016 | - | -$6.60 M(+75.2%) | -$19.46 M(+23.1%) |
| Jun 2016 | - | -$3.77 M(-30.8%) | -$15.80 M(+1.1%) |
| Mar 2016 | - | -$5.45 M(+49.9%) | -$15.63 M(+24.6%) |
| Dec 2015 | -$12.54 M(+97.6%) | -$3.64 M(+23.5%) | -$12.54 M(+19.7%) |
| Sep 2015 | - | -$2.94 M(-18.2%) | -$10.48 M(+12.1%) |
| Jun 2015 | - | -$3.60 M(+52.5%) | -$9.35 M(+28.5%) |
| Mar 2015 | - | -$2.36 M(+50.1%) | -$7.28 M(+14.7%) |
| Dec 2014 | -$6.35 M(+73.7%) | -$1.57 M(-13.4%) | -$6.35 M(+11.4%) |
| Sep 2014 | - | -$1.82 M(+19.1%) | -$5.70 M(+5.5%) |
| Jun 2014 | - | -$1.53 M(+6.7%) | -$5.40 M(+21.8%) |
| Mar 2014 | - | -$1.43 M(+54.8%) | -$4.43 M(+22.4%) |
| Dec 2013 | -$3.65 M(+60.5%) | -$923.20 K(-39.2%) | -$3.62 M(+12.3%) |
| Sep 2013 | - | -$1.52 M(+171.4%) | -$3.22 M(+35.6%) |
| Jun 2013 | - | -$559.30 K(-9.5%) | -$2.38 M(-14.0%) |
| Mar 2013 | - | -$617.80 K(+16.9%) | -$2.76 M(+21.4%) |
| Dec 2012 | -$2.28 M(-63.9%) | -$528.30 K(-21.3%) | -$2.28 M(-14.2%) |
| Sep 2012 | - | -$671.60 K(-29.0%) | -$2.65 M(-30.7%) |
| Jun 2012 | - | -$946.30 K(+627.4%) | -$3.83 M(-18.7%) |
| Mar 2012 | - | -$130.10 K(-85.6%) | -$4.71 M(-25.2%) |
| Dec 2011 | -$6.30 M(+71.2%) | -$904.60 K(-51.1%) | -$6.30 M(-5.0%) |
| Sep 2011 | - | -$1.85 M(+1.2%) | -$6.63 M(+13.4%) |
| Jun 2011 | - | -$1.83 M(+6.2%) | -$5.85 M(+13.3%) |
| Mar 2011 | - | -$1.72 M(+38.8%) | -$5.16 M(+40.3%) |
| Dec 2010 | -$3.68 M(+71.4%) | -$1.24 M(+16.5%) | -$3.68 M(+17.7%) |
| Sep 2010 | - | -$1.06 M(-6.6%) | -$3.13 M(+33.8%) |
| Jun 2010 | - | -$1.14 M(+379.2%) | -$2.34 M(+26.8%) |
| Mar 2010 | - | -$237.70 K(-65.3%) | -$1.84 M(-14.1%) |
| Dec 2009 | -$2.15 M | -$685.20 K(+149.5%) | -$2.15 M(+46.9%) |
| Sep 2009 | - | -$274.60 K(-57.5%) | -$1.46 M(+23.1%) |
| Jun 2009 | - | -$645.50 K(+19.3%) | -$1.19 M(+119.3%) |
| Mar 2009 | - | -$541.20 K | -$541.20 K |
FAQ
- What is CorMedix annual free cash flow?
- What is the all time high annual FCF for CorMedix?
- What is CorMedix annual FCF year-on-year change?
- What is CorMedix quarterly free cash flow?
- What is the all time high quarterly FCF for CorMedix?
- What is CorMedix quarterly FCF year-on-year change?
- What is CorMedix TTM free cash flow?
- What is the all time high TTM FCF for CorMedix?
- What is CorMedix TTM FCF year-on-year change?
What is CorMedix annual free cash flow?
The current annual FCF of CRMD is -$38.74 M
What is the all time high annual FCF for CorMedix?
CorMedix all-time high annual free cash flow is -$2.15 M
What is CorMedix annual FCF year-on-year change?
Over the past year, CRMD annual free cash flow has changed by -$14.16 M (-57.62%)
What is CorMedix quarterly free cash flow?
The current quarterly FCF of CRMD is -$13.66 M
What is the all time high quarterly FCF for CorMedix?
CorMedix all-time high quarterly free cash flow is $160.90 K
What is CorMedix quarterly FCF year-on-year change?
Over the past year, CRMD quarterly free cash flow has changed by -$2.62 M (-23.71%)
What is CorMedix TTM free cash flow?
The current TTM FCF of CRMD is -$56.15 M
What is the all time high TTM FCF for CorMedix?
CorMedix all-time high TTM free cash flow is -$541.20 K
What is CorMedix TTM FCF year-on-year change?
Over the past year, CRMD TTM free cash flow has changed by -$17.41 M (-44.95%)